Success Metrics

Clinical Success Rate
62.5%

Based on 10 completed trials

Completion Rate
63%(10/16)
Active Trials
1(4%)
Results Posted
30%(3 trials)
Terminated
6(25%)

Phase Distribution

Ph not_applicable
7
29%
Ph phase_1
11
46%
Ph phase_2
6
25%

Phase Distribution

11

Early Stage

6

Mid Stage

0

Late Stage

Phase Distribution24 total trials
Phase 1Safety & dosage
11(45.8%)
Phase 2Efficacy & side effects
6(25.0%)
N/ANon-phased studies
7(29.2%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

62.5%

10 of 16 finished

Non-Completion Rate

37.5%

6 ended early

Currently Active

1

trials recruiting

Total Trials

24

all time

Status Distribution
Active(1)
Completed(10)
Terminated(6)
Other(7)

Detailed Status

Completed10
unknown7
Terminated6
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
24
Active
1
Success Rate
62.5%
Most Advanced
Phase 2

Trials by Phase

Phase 111 (45.8%)
Phase 26 (25.0%)
N/A7 (29.2%)

Trials by Status

active_not_recruiting14%
terminated625%
unknown729%
completed1042%

Recent Activity

Clinical Trials (24)

Showing 20 of 24 trialsScroll for more
NCT00576979Phase 1

Intensity-Modulated Radiation Therapy, Etoposide, and Cyclophosphamide Followed By Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia

Completed
NCT04281199Phase 1

TBI Using IMRT (VMAT or Tomotherapy) for the Prevention of Pul Toxicities in Patients Undergoing Donor SCT

Active Not Recruiting
NCT02000050Phase 2

Phase II Study of Up-front Chemotherapy and Neo-adjuvant Short-course Radiotherapy for Resectable Rectal Carcinoma (COLORE)

Completed
NCT00540995Phase 1

Busulfan, Etoposide, and Intensity-Modulated Radiation Therapy Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Myeloid Cancer

Terminated
NCT03553212Not Applicable

Twice High Dose External Beam Radiotherapy by Image-guided Tomotherapy for Organ-confined Prostate Cancer Treatment Emulating High Dose Radiation (HDR) Brachytherapy

Terminated
NCT02858934Not Applicable

Feasibility Study of Accelerated Preoperative Radiotherapy for Early Breast Cancer

Completed
NCT01730651Not Applicable

High Dose Intensity Modulated Radiation Therapy in the Cervical Cancer With Metastatic Lymphadenopathies.

Unknown
NCT04178343Not Applicable

Tomotherapy for Leptomeningeal Metastases

Completed
NCT04178330Not Applicable

Tomotherapy as Primary Radiotherapy for Multipule Brain Metastases

Completed
NCT00623077Phase 1

MT2004-30: Tomotherapy for Solid Tumors

Terminated
NCT00459628Not Applicable

Trial of Tomotherapy in Breast Cancer

Unknown
NCT03027544Not Applicable

Tomotherapy for Refractory Brain Metastases

Unknown
NCT00550654Phase 2

Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain

Terminated
NCT00126802Phase 1

The Role of Tomotherapy in Hypofractionated/Dose Escalated Conformal Radiation Treatment for High Risk Prostate Cancer

Unknown
NCT00754078Phase 2

A Phase II Study to Assess Acute Toxicity and Quality of Life of Patients With Carcinoma of the Anal Canal Receiving Chemotherapy and Radiation Using Helical Tomotherapy

Unknown
NCT00128986Phase 1

Study of Tomotherapy in Patients With Benign Brain Tumour

Completed
NCT00469196Phase 2

Tomotherapy Treatment for Mesothelioma

Completed
NCT00129012Phase 1

Self-Gated Breath-Hold Technique for Helical Tomotherapy in Patients With Non-Small Cell Lung Cancer

Completed
NCT01118897Phase 1

Tomotherapy in Locally Advanced Gallbladder and Pancreatic Cancers

Completed
NCT00800150Phase 1

Total Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematological Cancer That Has Not Responded to Treatment

Terminated

Drug Details

Intervention Type
RADIATION
Total Trials
24